News
-
ACLA Comments on 2016 ONC Draft Interoperability Advisory
... -
ACLA Comments on MAAA Testing and Other Preliminary Determinations
... -
ACLA Comments on DOA and Other Preliminary Determinations
... -
Reform the IOAS self-referral exception
ACLA and stakeholders ask Congress to support integrity in the practice of medicine and soften the blow to seniors by narrowing the IOAS exception, saving billions in Medicare and easing the pain of a Medicare Part B spike in premiums to certain seniors. Read more: https://thehill.com/blogs/congress-blog/healthcare/255696-reform-the-ioas-self-referral-exception ... -
ACLA Warns CMS’ Proposed Coding and Payment Proposals that Pose Draconian Cuts to Innovative Life-Saving Diagnostics Will Jeopardize the Advancement of Personalized Medicine
... -
ACLA Expresses Serious Concerns About CMS’ Proposed Rule on Provisions in the Protecting Access to Medicare Act (PAMA)
... -
Statement from the American Clinical Laboratory Association on the announcement by CMS of Appointees to the Advisory Panel on Clinical Diagnostic Laboratory Tests
... -
ACLA Letter on Medicare Advantage Compliance Program Requirements for FDRs
... -
ACLA Comments on Proposed Rule for Modifications to Meaningful Use in 2015 through 2017
... -
ACLA Letter to ONC Regarding Estimate of Benefits for eDOS Adoption
...
